These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 36162436)
1. MicroRNA-382-5p Promotes Oral Squamous Cell Carcinoma Development and Progression by Negatively Regulating PTEN Expression. Xu X; Jin B; Cai L; Zhang Z; Ying Y; Luo J J Oral Maxillofac Surg; 2022 Dec; 80(12):2015-2023. PubMed ID: 36162436 [TBL] [Abstract][Full Text] [Related]
2. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p. Han L; Cheng J; Li A Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508 [No Abstract] [Full Text] [Related]
3. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition. Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832 [TBL] [Abstract][Full Text] [Related]
4. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression. Niu X; Yang B; Liu F; Fang Q Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187 [TBL] [Abstract][Full Text] [Related]
5. MiR-590-5p regulates cell proliferation, apoptosis, migration and invasion in oral squamous cell carcinoma by targeting RECK. Bao WW; Shi YL; Ma Y; Qu XH; Pang GM; Yang L Histol Histopathol; 2021 Mar; 36(3):355-365. PubMed ID: 33447989 [TBL] [Abstract][Full Text] [Related]
6. FOXN3 Expression Regulated by miR-299-5p Inhibiting the Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma Cells. Maimaitiming K; Yilihamu A; Keyimu K; Keranmu R; Li J; Xu H; Wufuer D Protein Pept Lett; 2022; 29(9):788-795. PubMed ID: 35975858 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-99a-5p suppresses cell proliferation, migration, and invasion by targeting isoprenylcysteine carboxylmethyltransferase in oral squamous cell carcinoma. Sun X; Yan H J Int Med Res; 2021 May; 49(5):300060520939031. PubMed ID: 34038200 [TBL] [Abstract][Full Text] [Related]
8. circ_0004872 inhibits proliferation, invasion, and glycolysis of oral squamous cell carcinoma by sponged miR-424-5p. Dai Y; Zhu Y; Xu H J Clin Lab Anal; 2022 Jul; 36(7):e24486. PubMed ID: 35576499 [TBL] [Abstract][Full Text] [Related]
9. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3. He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147 [TBL] [Abstract][Full Text] [Related]
10. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2. Wang X; Zhang Y; Zhang S; Duan L Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169 [TBL] [Abstract][Full Text] [Related]
11. LINC01123 is associated with prognosis of oral squamous cell carcinoma and involved in tumor progression by sponging miR-34a-5p. Qin H; Wang C; Hua Y Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jan; 133(1):50-59. PubMed ID: 34511356 [TBL] [Abstract][Full Text] [Related]
12. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma. Zhu X; Du J; Gu Z Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775 [TBL] [Abstract][Full Text] [Related]
13. Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21. Zhang LL; Hu D; Zou LH Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8315-8323. PubMed ID: 30556872 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-182-5p Modulates Oral Squamous Cell Carcinoma Migration and Invasion Via Targeting MTSS1 Gene. Guo Y; Qiao X; Zhu L; Song R Pathol Oncol Res; 2020 Apr; 26(2):1007-1013. PubMed ID: 30949866 [TBL] [Abstract][Full Text] [Related]
15. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR. Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300 [TBL] [Abstract][Full Text] [Related]
16. LncRNA DLEU1 facilitates the progression of oral squamous cell carcinoma by miR-126-5p/GAB1 axis. Sun KD; Ni YJ; Qin H; Xu QF Kaohsiung J Med Sci; 2022 Oct; 38(10):950-959. PubMed ID: 36039933 [TBL] [Abstract][Full Text] [Related]
17. Hsa_circRNA_0001971 contributes to oral squamous cell carcinoma progression via miR-186-5p/Fibronectin type III domain containing 3B axis. Zhang J; Peng Y; Jiang S; Li J J Clin Lab Anal; 2022 Mar; 36(3):e24245. PubMed ID: 35060189 [TBL] [Abstract][Full Text] [Related]
18. Circ_0005320 promotes oral squamous cell carcinoma tumorigenesis by sponging microRNA-486-3p and microRNA-637. Zheng X; Du F; Gong X; Xu P Bioengineered; 2022 Jan; 13(1):440-454. PubMed ID: 34967281 [TBL] [Abstract][Full Text] [Related]
19. MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2. Wu M; Duan Q; Liu X; Zhang P; Fu Y; Zhang Z; Liu L; Cheng J; Jiang H Biomed Pharmacother; 2020 Feb; 122():109696. PubMed ID: 31918270 [TBL] [Abstract][Full Text] [Related]